Viyash Scientific — 360° view

Viyash Scientific, a company in the Pharmaceuticals industry, reported revenue of ₹988 crore and net profit of ₹85 crore for the September 2026 quarter.

Viyash Scientific (NSE: VIYASH) closed at ₹233.36 on 20 Nov 2026, down 2.6% over the past year. Its market capitalisation is ₹10,314 crore and it trades at 42.6 times earnings.

Share price
₹233.36 (20 Nov 2026)
Market cap
₹10,314 Cr (20 Nov 2026)
P/E
42.62 (20 Nov 2026)
Revenue
₹988 Cr (September 2026 quarter)
Net profit
₹85 Cr (September 2026 quarter)
ROCE
13.4% (FY26)
ROE
7.39% (FY26)
Book value
₹71.7 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹298.00 / ₹178.13 (20 Nov 2026)
1-year return
-2.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: VIYASH

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.